Proteomics & Metabolomics Core Facility @ Weill Cornell
Proteomics & Metabolomics Core Facility @ Weill Cornell
Established in 2016, the Weill Cornell Medicine (WCM) Meyer Cancer Center Proteomics and Metabolomics Core Facility provides mass spectrometry based analysis of proteins, peptides, metabolites and other biochemical molecules.
The core facility is open to Weill Cornell Medicine users as well as external users from academic institutions and commercial enterprises.
For more information, please visit our iLab website.
2018-01 We release new service: Full panel tracing of C13 labeled polar metabolites.